UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first‐line palliative chemotherapy

Cancer, 2009-09, Vol.115 (18), p.4148-4155

2009

Volltextzugriff (PDF)

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.933-939

2019

Volltextzugriff (PDF)

Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-04, Vol.18 (2), p.346-353

2015

Volltextzugriff (PDF)

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer

Clinical cancer research, 2020-07, Vol.26 (13), p.3287-3295

2020

Volltextzugriff (PDF)

Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma

International journal of hyperthermia, 2010, Vol.26 (4), p.305-315

2010

Volltextzugriff (PDF)

Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation

PLoS medicine, 2014-12, Vol.11 (12), p.e1001770

2014

Volltextzugriff (PDF)

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

Oncoimmunology, 2024-12, Vol.13 (1), p.2371563

2024

Volltextzugriff (PDF)

Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107509, Article 107509

2024

Volltextzugriff (PDF)

Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer

Clinical cancer research, 2016-12, Vol.22 (24), p.6228-6235

2016

Volltextzugriff (PDF)

Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing

PloS one, 2019-11, Vol.14 (11), p.e0224379-e0224379

2019

Volltextzugriff (PDF)

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer

EMBO molecular medicine, 2019-12, Vol.11 (12), p.e10581-n/a

2019

Volltextzugriff (PDF)

Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2012-07, Vol.15 (3), p.305-312

2012

Volltextzugriff (PDF)

Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.30-30, Article 30

2019

Volltextzugriff (PDF)

Brain metastases in breast cancer: prognostic factors and management

Breast cancer research and treatment, 2008-10, Vol.111 (3), p.523-530

2008

Volltextzugriff (PDF)

Biochemical Characterization of Metnase’s Endonuclease Activity and Its Role in NHEJ Repair

Biochemistry (Easton), 2011-05, Vol.50 (20), p.4360-4370

2011

Volltextzugriff (PDF)

Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Journal of clinical oncology, 2010-08, Vol.28 (24), p.3824-3829

2010

Volltextzugriff (PDF)

Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study

Cancer medicine (Malden, MA), 2024-04, Vol.13 (7), p.e7174-n/a

2024

Volltextzugriff (PDF)

YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment

Frontiers in chemistry, 2022-12, Vol.10, p.998013-998013

2022

Volltextzugriff (PDF)

A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models

Cancer chemotherapy and pharmacology, 2011-10, Vol.68 (4), p.913-921

2011

Volltextzugriff (PDF)

Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents

Bioorganic & medicinal chemistry, 2010-10, Vol.18 (19), p.7092-7100

2010

Volltextzugriff (PDF)

Comparison of prognostic genomic predictors in colorectal cancer

PloS one, 2013-04, Vol.8 (4), p.e60778-e60778

2013

Volltextzugriff (PDF)

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

Clinical & translational immunology, 2022, Vol.11 (1), p.e1364-n/a

2022

Volltextzugriff (PDF)

Intramedullary spinal cord metastases: a single-institution experience

Journal of neuro-oncology, 2007-08, Vol.84 (1), p.85-89

2007

Volltextzugriff (PDF)

Design and Biological Evaluation of Novel Tubulin Inhibitors as Antimitotic Agents Using a Pharmacophore Binding Model with Tubulin

Journal of medicinal chemistry, 2006-09, Vol.49 (19), p.5664-5670

2006

Volltextzugriff (PDF)

Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea

Breast cancer research and treatment, 2011-07, Vol.128 (1), p.171-177

2011

Volltextzugriff (PDF)

1 – 25 von 5.729

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.691)
Mit Volltextzugriff
(4.506)

Publikationsform

Sprache

Englisch
(4.563)
Koreanisch
(1.149)
Japanisch
(538)
Russisch
(4)
Chinesisch
(2)
Deutsch
(2)
Norwegisch
(1)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first‐line palliative chemotherapy

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer

Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma

Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201

Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer

Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer

Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients

Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial

Brain metastases in breast cancer: prognostic factors and management

Biochemical Characterization of Metnase’s Endonuclease Activity and Its Role in NHEJ Repair

Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study

YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment

A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models

Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents

Comparison of prognostic genomic predictors in colorectal cancer

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

Intramedullary spinal cord metastases: a single-institution experience

Design and Biological Evaluation of Novel Tubulin Inhibitors as Antimitotic Agents Using a Pharmacophore Binding Model with Tubulin

Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea

Suchergebnisse filtern